David A Zaharoff

Title: Innovations by David A. Zaharoff in Engineered FGF Compositions

Introduction

David A. Zaharoff, an innovative inventor based in Morrisville, NC, has made significant contributions to the field of biotechnology. With a focus on engineered fibroblast growth factors (FGFs), Zaharoff's work aims to enhance therapeutic applications in various medical conditions.

Latest Patents

Zaharoff holds a notable patent titled "Engineered FGF compositions and methods of use thereof." This invention focuses on the development of stable mutants of FGF-1 and FGF-2. The patent encompasses novel engineered polypeptides and their corresponding polynucleotides, DNA constructs, and vectors encoding these polypeptides. Additionally, it provides pharmaceutical compositions and hydrogels that incorporate these innovations. The patent also outlines methods for treating medical conditions utilizing the disclosed compositions, marking a significant advancement in the field.

Career Highlights

David A. Zaharoff has established himself as a leading researcher at the University of Arkansas. His dedication to advancing medical therapeutics through biotechnological innovation has garnered attention in the scientific community. With a single, impactful patent to his name, Zaharoff continues to contribute to the improvement of health outcomes through his inventive approaches.

Collaborations

Zaharoff collaborates with esteemed colleagues Suresh Kumar Thallapuranam and Srinivas Jayanthi. Their partnership enhances the research and development efforts, promoting innovation in the application of engineered proteins and therapeutic compositions.

Conclusion

David A. Zaharoff exemplifies the spirit of innovation, contributing valuable insights and inventions that hold great potential for the future of medical treatments. His work on engineered FGFs not only represents his expertise but also highlights the ongoing advancements in biotechnology that can lead to significant improvements in healthcare.